GLP-1 Medications and Plastic Surgery: What Patients Need to Know

The GLP-1 Revolution and Its Impact on Plastic Surgery

The rise of GLP-1 receptor agonist medications—Ozempic (semaglutide), Mounjaro (tirzepatide), and Wegovy—has transformed weight management worldwide. But rapid, significant weight loss creates new aesthetic concerns that are driving unprecedented demand for plastic surgery. Prof. Dr. Mehmet Veli Karaaltin explores the intersection of these medications and modern body contouring.

What Are GLP-1 Medications?

GLP-1 (glucagon-like peptide-1) receptor agonists were originally developed for type 2 diabetes management. They work by mimicking a natural hormone that regulates appetite, slowing gastric emptying, and promoting satiety. Patients typically lose 15–25% of their body weight over 12–18 months.

The Aesthetic Consequences of Rapid Weight Loss

While the health benefits are significant, rapid weight loss often leaves patients with:

• Excess skin: The skin cannot retract fast enough, leaving loose, hanging tissue on the abdomen, arms, thighs, and face
• "Ozempic Face": Facial volume loss causing a gaunt, aged appearance with prominent nasolabial folds and hollow cheeks
• Deflated breasts: Loss of breast volume and ptosis (sagging)
• Loose neck skin: Creating a "turkey neck" appearance

Procedures in High Demand Post-GLP-1

Body Contouring

Abdominoplasty (tummy tuck) remains the most requested procedure. Prof. Dr. Karaaltin's approach combines skin excision with liposuction and Vibrosat Pro™ vibration-assisted technology for smoother contours.

Brachioplasty (arm lift) and thigh lift procedures address hanging skin on the extremities. Dr. Karaaltin places incisions in concealed locations to minimise visible scarring.

Facial Rejuvenation

The K-Face Lift™ and microfat grafting restore lost facial volume and tighten skin simultaneously. Fat transfer using Stempia™ enrichment provides long-lasting volume restoration to the cheeks, temples, and perioral region.

Breast Restoration

Post-weight-loss breast surgery often combines a breast lift (mastopexy) with either implants or fat transfer to restore shape and volume. Dr. Karaaltin's TwirlBra™ internal support technique ensures long-lasting lift results.

Timing Surgery After GLP-1 Treatment

Prof. Dr. Karaaltin recommends patients:

1. Achieve weight stability for at least 3–6 months before surgery
2. Maintain a stable BMI within their target range
3. Discuss medication management with their prescribing physician—some surgeons recommend pausing GLP-1 medications 2–3 weeks before surgery due to potential anaesthesia interactions
4. Optimise nutrition to counteract the protein deficiency common with appetite suppression

The Future of Post-Weight-Loss Surgery

As GLP-1 medications become more widespread, the demand for body contouring is projected to grow significantly. Prof. Dr. Karaaltin's clinic is at the forefront of this trend, combining advanced techniques like Advanced Safe BBL™, Vibrosat Pro™, and Stempia™ fat enrichment to help post-GLP-1 patients achieve their ideal body contour safely and effectively.